Science Daily·4 min read·hard
New autism therapy shows surprising benefits even in adult mice
✦AI Summary
Researchers have identified a potential new treatment for autism spectrum disorder by targeting the Slc6a20a brain receptor. By reducing this transporter's activity, the team successfully restored NMDA receptor function in mouse models, offering a more precise alternative to previous, less effective therapies.
Researchers have uncovered a potential new way to treat autism spectrum disorder (ASD) by restoring the function of an important brain receptor. The study, led by Director Eunjoon Kim of the IBS Center for Synaptic Brain Dysfunctions, focused on a glycine transporter known as Slc6a20a/SLC6A20.
sciencehealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in